Want to see JP:2269 full AI Analyst Report?
Meiji Holdings Co (2269) AI Stock Analysis
Meiji Holdings Co
(TSE/TYO:2269)
Solid technical momentum and stable balance sheet drive the score, offset by profitability declines and elevated valuation; cash flow weaknesses pose key risks.
Meiji Holdings Co (2269) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 5.49B
- Dividend Yield
- 2.53%
- Average Volume (3M)
- 1.13M
- Price to Earnings (P/E)
- 29.8
- Beta (1Y)
- 0.16
- Revenue Growth
- 3.53%
- EPS Growth
- -14.19%
- Country
- Japan
- Employees
- 17,103
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Packaged Foods
Meiji Holdings Co Business Overview & Revenue Model
Company Description
Meiji Holdings Co., Ltd., established in Tokyo, Japan, in 1916, operates globally as a prominent manufacturer and seller across two core business segments: Food and Pharmaceutical. Its extensive Food division produces and markets a wide array of prod...
How the Company Makes Money
Meiji Holdings makes money primarily through the operating revenues of its major subsidiaries across two main segments: (1) Food & Nutrition and (2) Pharmaceuticals. In Food & Nutrition, revenue is generated from selling branded consumer products—esp...
Meiji Holdings Co Earnings Call Summary
The earnings call presented a mixed picture with strong performances in the Pharmaceutical segment and growth in certain brands, but faced challenges in the Food segment, particularly in China and the U.S. The decline in profits and the revised vaccine outlook were notable concerns.
Q2-2025 Updates
Positive Updates
Negative Updates
Company Guidance
In the earnings call for Q2 2025, Meiji Holdings provided comprehensive guidance on its financial performance and future outlook. For the first half of fiscal 2024, the company reported consolidated net sales of JPY 569.0 billion, marking a 4.2% increase year-on-year. However, operating profit remained steady at JPY 44.3 billion, while profit attributable to owners of the parent decreased by 3.8% to JPY 26.8 billion due to lower extraordinary gains. The Food segment experienced a 2.2% increase in net sales to JPY 455.4 billion, although operating profit declined by 6.9% year-on-year, affected by increased raw material costs and challenges in overseas operations. Meanwhile, the Pharmaceutical segment saw a significant boost, with net sales rising by 12.9% to JPY 113.8 billion and operating profit increasing by 16.7% to JPY 18.5 billion, aided by strong sales of antibacterial injections and influenza vaccines. For the second half, Meiji plans to achieve a year-on-year increase in consolidated net sales to JPY 589.9 billion and an operating profit of JPY 41.6 billion, focusing on price adjustments and strategic marketing to counter cost pressures.
Meiji Holdings Co Financial Statement Overview
Summary
Meiji Holdings exhibits mixed financials with steady revenue growth and a strong balance sheet featuring low debt and growing equity, but declining net margins, ROE, and negative free cash flow indicate profitability and liquidity challenges.
Income Statement
60NeutralBalance Sheet
75PositiveCash Flow
40Negative| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.19T | 1.15T | 1.17T | 1.11T | 1.06T | 1.01T |
| Gross Profit | 367.91B | 339.10B | 359.04B | 327.35B | 306.80B | 323.25B |
| EBITDA | 126.55B | 137.84B | 123.97B | 143.20B | 149.46B | 179.07B |
| Net Income | 40.25B | 50.80B | 35.08B | 50.67B | 69.42B | 87.50B |
Balance Sheet | ||||||
| Total Assets | 1.29T | 1.18T | 1.26T | 1.21T | 1.14T | 1.12T |
| Cash, Cash Equivalents and Short-Term Investments | 86.35B | 78.19B | 69.25B | 106.86B | 63.52B | 67.41B |
| Total Debt | 138.26B | 52.13B | 112.58B | 54.77B | 69.18B | 82.46B |
| Total Liabilities | 468.26B | 392.69B | 444.20B | 417.49B | 384.90B | 404.44B |
| Stockholders Equity | 772.33B | 748.29B | 772.59B | 746.53B | 711.92B | 673.34B |
Cash Flow | ||||||
| Free Cash Flow | -27.68B | 12.36B | -47.23B | 54.54B | 16.20B | 39.21B |
| Operating Cash Flow | 76.39B | 68.98B | 56.52B | 107.98B | 85.01B | 127.53B |
| Investing Cash Flow | -99.72B | -40.64B | -110.38B | -24.60B | -36.79B | -27.61B |
| Financing Cash Flow | 17.69B | -61.67B | 34.60B | -43.77B | -54.73B | -77.00B |
Meiji Holdings Co Peers Comparison
Overall Rating
JP:227074Outperform
JP:280968Neutral- JP:226965Neutral
JP:280263Neutral
JP:226459Neutral
JP:220655Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:2270 | 74Outperform | JPY 216.53B | 5.91 | ― | 2.82% | 0.44% | 138.68% |
| JP:2809 | 68Neutral | JPY 634.42B | 25.67 | 7.92% | 1.40% | 4.07% | -6.32% |
| JP:2269 | 65Neutral | JPY 1.18T | 29.77 | 5.27% | 2.53% | 3.53% | -14.19% |
| JP:2802 | 63Neutral | JPY 4.80T | 35.22 | 18.50% | 0.99% | 6.72% | 83.84% |
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
| JP:2264 | 59Neutral | JPY 355.70B | 15.04 | ― | 2.37% | 1.89% | 227.30% |
| JP:2206 | 55Neutral | JPY 325.85B | 51.99 | 2.29% | 1.89% | 10.44% | -22.76% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:2269 | Meiji Holdings Co | 4422.00 | 1416.21 | 47.12% | |
| JP:2802 | Ajinomoto Co | 4872.00 | 1286.19 | 35.87% | |
| JP:2809 | Kewpie Corporation | 4809.00 | 590.15 | 13.99% | |
| JP:2206 | Ezaki Glico Co., Ltd. | 5189.00 | 186.47 | 3.73% | |
| JP:2264 | Morinaga Milk Industry Co., Ltd. | 1139.50 | 304.57 | 36.48% | |
| JP:2270 | MEGMILK SNOW BRAND Co., Ltd. | 3705.00 | 924.23 | 33.24% |
Meiji Holdings Co Corporate Events
Meiji Holdings Delivers Strong Q1 Profits and Confirms Outlook
Meiji Holdings reported solid first-quarter results for the fiscal year ending March 31, 2027, with net sales rising 5.8% to JPY 289.4 billion and operating profit surging 27.7% to JPY 22.7 billion. Profit attributable to owners of parent climbed 51....
Meiji Holdings Completes Restricted Stock Compensation Payment for Executives
Meiji Holdings has completed full payment for the disposal of 64,827 shares of its treasury stock, which are being used as restricted stock compensation for directors and executive officers at both the parent company and its group companies. The shar...
Meiji Reshapes China Strategy With Sale of Dairy and B2B Units
Meiji Holdings has decided to transfer its dairy and B2B businesses in China, including drinking milk and yogurt operations run through several local subsidiaries, to Shanghai AustAsia Food as part of a strategic overhaul of its Chinese portfolio. Th...
Meiji Holdings to Grant Restricted Treasury Shares to Managerial Staff
Meiji Holdings has approved the disposal of 16,400 shares of its treasury stock as restricted stock to 164 managerial employees across the parent company and key subsidiaries, with a total value of about JPY 62.4 million and a payment date set for Se...
Meiji Holdings to Dispose Treasury Shares for Restricted Stock Compensation
Meiji Holdings Co., Ltd. will dispose of 64,827 shares of its treasury stock at ¥3,805 per share, with a total value of about ¥246.7 million, to provide restricted stock compensation to 52 directors and executive officers across the parent...
Meiji Holdings Raises Year-End Dividend, Lifts Annual Payout to 105 Yen Per Share
Meiji Holdings has approved a year-end surplus dividend of 52.50 yen per share for the fiscal year ended March 31, 2026, up from 50.00 yen a year earlier, bringing the total annual dividend to 105.00 yen per share. The company said the payout, effect...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 07, 2026